These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8446612)

  • 1. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.
    Gidh-Jain M; Takeda J; Xu LZ; Lange AJ; Vionnet N; Stoffel M; Froguel P; Velho G; Sun F; Cohen D
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1932-6. PubMed ID: 8446612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular model of human beta-cell glucokinase built by analogy to the crystal structure of yeast hexokinase B.
    St Charles R; Harrison RW; Bell GI; Pilkis SJ; Weber IT
    Diabetes; 1994 Jun; 43(6):784-91. PubMed ID: 8194664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants.
    Takeda J; Gidh-Jain M; Xu LZ; Froguel P; Velho G; Vaxillaire M; Cohen D; Shimada F; Makino H; Nishi S
    J Biol Chem; 1993 Jul; 268(20):15200-4. PubMed ID: 8325892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus.
    Stoffel M; Froguel P; Takeda J; Zouali H; Vionnet N; Nishi S; Weber IT; Harrison RW; Pilkis SJ; Lesage S
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7698-702. PubMed ID: 1502186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.
    Miller SP; Anand GR; Karschnia EJ; Bell GI; LaPorte DC; Lange AJ
    Diabetes; 1999 Aug; 48(8):1645-51. PubMed ID: 10426385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.
    Liang Y; Kesavan P; Wang LQ; Niswender K; Tanizawa Y; Permutt MA; Magnuson MA; Matschinsky FM
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):167-73. PubMed ID: 7619052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human beta-cell glucokinase. Dual role of Ser-151 in catalysis and hexose affinity.
    Xu LZ; Harrison RW; Weber IT; Pilkis SJ
    J Biol Chem; 1995 Apr; 270(17):9939-46. PubMed ID: 7730377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2).
    Kesavan P; Wang L; Davis E; Cuesta A; Sweet I; Niswender K; Magnuson MA; Matschinsky FM
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):57-63. PubMed ID: 9078243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human glucokinase intrinsic activity by SH reagents mirrors post-translational regulation of enzyme activity.
    Tiedge M; Krug U; Lenzen S
    Biochim Biophys Acta; 1997 Feb; 1337(2):175-90. PubMed ID: 9048894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucokinase gene variants in the common form of NIDDM.
    Chiu KC; Tanizawa Y; Permutt MA
    Diabetes; 1993 Apr; 42(4):579-82. PubMed ID: 8454109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
    Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus.
    Froguel P; Zouali H; Vionnet N; Velho G; Vaxillaire M; Sun F; Lesage S; Stoffel M; Takeda J; Passa P
    N Engl J Med; 1993 Mar; 328(10):697-702. PubMed ID: 8433729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene.
    Bali D; Svetlanov A; Lee HW; Fusco-DeMane D; Leiser M; Li B; Barzilai N; Surana M; Hou H; Fleischer N
    J Biol Chem; 1995 Sep; 270(37):21464-7. PubMed ID: 7665557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations.
    Sturis J; Kurland IJ; Byrne MM; Mosekilde E; Froguel P; Pilkis SJ; Bell GI; Polonsky KS
    Diabetes; 1994 May; 43(5):718-23. PubMed ID: 8168650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of two MODY2 mutations with different susceptibility to activation.
    Langer S; Platz C; Waterstradt R; Baltrusch S
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1113-1119. PubMed ID: 26208450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unequal potency of transgenic yeast hexokinase on pancreatic beta cell metabolism and secretion.
    Xu B; Epstein PN
    Endocr Res; 1996 May; 22(2):147-58. PubMed ID: 8799694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase.
    Tiedge M; Richter T; Lenzen S
    Arch Biochem Biophys; 2000 Mar; 375(2):251-60. PubMed ID: 10700381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.